Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
Debt Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR+13.6%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
+13.6%/yr
Quarterly compound
Percentile
P77
Within normal range
vs 3Y Ago
1.5x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.41% |
| Q3 2025 | -19.88% |
| Q2 2025 | 1.06% |
| Q1 2025 | 4.25% |
| Q4 2024 | -9.29% |
| Q3 2024 | 10.94% |
| Q2 2024 | 2.77% |
| Q1 2024 | -14.37% |
| Q4 2023 | -15.15% |
| Q3 2023 | -10.11% |
| Q2 2023 | -9.70% |
| Q1 2023 | 0.10% |
| Q4 2022 | 3.69% |
| Q3 2022 | 8.55% |
| Q2 2022 | 11.19% |
| Q1 2022 | -1.54% |
| Q4 2021 | -3.10% |
| Q3 2021 | 11.52% |
| Q2 2021 | -1.88% |
| Q1 2021 | -0.09% |
| Q4 2020 | -0.21% |
| Q3 2020 | -0.56% |
| Q2 2020 | -3.46% |
| Q1 2020 | -9.25% |
| Q4 2019 | -3.83% |
| Q3 2019 | -7.48% |
| Q2 2019 | 72.22% |
| Q1 2019 | 37.74% |
| Q4 2018 | -1.86% |
| Q3 2018 | -4.06% |
| Q2 2018 | 78.63% |
| Q1 2018 | -2.97% |
| Q4 2017 | 35.28% |
| Q3 2017 | -11.53% |
| Q2 2017 | -7.68% |
| Q1 2017 | -11.43% |
| Q4 2016 | 79.50% |
| Q3 2016 | -22.35% |
| Q2 2016 | -11.29% |
| Q1 2016 | -21.74% |